- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Institut d'investigació
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de Gustave Roussy Cancer Campus](/img/noimage_org.png)
Gustave Roussy Cancer Campus
Villejuif, FranciaPublications en collaboration avec des chercheurs de Gustave Roussy Cancer Campus (7)
2023
-
Buffy coat signatures of breast cancer risk in a prospective cohort study
Clinical Epigenetics, Vol. 15, Núm. 1
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2017
2014
-
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer
Nature Genetics, Vol. 46, Núm. 7, pp. 736-741
2007
-
Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries
International Journal of Cancer, Vol. 121, Núm. 4, pp. 825-831
-
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents
Journal of Medical Genetics, Vol. 44, Núm. 2, pp. 99-106
2006
-
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
Cancer Research, Vol. 66, Núm. 20, pp. 9818-9828